Latest Regulatory News

Nova Eye Medical has reported a record A$29.2 million revenue for FY25, driven by strong sales growth and improved profitability in its glaucoma segment. The company targets breakeven EBITDA in the first half of FY26 amid promising regulatory and market developments.

EDU Holdings reports a modest 2% increase in total student enrolments for its Australian Learning Group in Term 3, 2025, while new student enrolments have sharply declined amid ongoing regulatory challenges.

Terramin Australia reports steady progress across multiple projects including key drilling at Tala Hamza and regulatory approvals at Kapunda, while navigating legal challenges at Bird in Hand. Algeria’s recent mining reforms offer a promising backdrop for the company’s expansion plans.

New World Resources has upgraded its Antler Copper Deposit resource to 14.2 million tonnes at 3.8% copper equivalent, secured key permitting milestones, and recommended shareholders accept a $0.067 per share takeover offer from Kinterra Capital.

LTR Pharma has initiated commercial distribution of its nasal spray SPONTAN through Australia's Symbion pharmacy network and is advancing ROXUS development for a US launch in early 2026, while expanding its pipeline with a new intranasal treatment for swallowing disorders.

EMVision Medical Devices has secured ethics approvals for two pivotal clinical studies and received a $400,000 milestone payment, marking significant progress toward commercialising its portable First Responder brain scanner.

Wildcat Resources has completed a positive Preliminary Feasibility Study for its Tabba Tabba lithium project in Western Australia, confirming a long-life mine with strong financial metrics and a clear path to development.

Viva Energy has reported a stronger-than-expected first half EBITDA, buoyed by operational efficiencies and refinery margins, even as convenience sales face headwinds from tobacco regulation.

Turners Automotive Group has issued over 324,000 new shares under its Dividend Reinvestment Plan for the FY25 final dividend, slightly increasing its capital base.

Domain Holdings Australia has received a draft class ruling from the ATO that aligns with its previously disclosed tax positions for the upcoming CoStar acquisition scheme. The final ruling, expected post-implementation, will provide definitive tax clarity for shareholders.

Bioxyne Limited has reported record revenue and cash flow for FY25, driven by robust growth in the Australian medical cannabis market and strategic advances into Europe and the UK.

Capricorn Metals has received regulatory approval to expand its Karlawinda operations, enabling a 25% increase in gold production to 150,000 ounces annually. Construction is set to accelerate with key contracts extended and infrastructure upgrades underway.